Moody’s revises Ferroglobe’s outlook to negative, affirms B2 rating
Bruce K. Posey, Chief Legal Officer of Qualys, Inc. (NASDAQ:QLYS), a cybersecurity firm with impressive 81.84% gross profit margins and a market capitalization of $4.87 billion, sold a total of 525 shares of common stock on September 22, 2025, for approximately $71,496. InvestingPro analysis shows the company maintains a GREAT financial health score, with strong cash positions exceeding debt levels.
The sales were executed in two separate transactions. The prices for these sales ranged from $135.9405 to $136.4424, near the middle of the stock’s 52-week range of $112.61 to $170.00. Posey still owns 57,315 shares after the transactions. According to InvestingPro, which offers comprehensive insider trading analysis among its 12+ additional insights for Qualys, management has been actively buying back shares, suggesting continued confidence in the company’s prospects.
The sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.
In other recent news, Qualys reported impressive second-quarter 2025 financial results, with earnings per share reaching $1.68, surpassing the forecasted $1.47. Revenue also exceeded expectations, totaling $164.1 million compared to the anticipated $161.24 million. Additionally, Qualys achieved FedRAMP High Authorization for its Government Platform, a significant milestone sponsored by the U.S. Drug Enforcement Agency. This authorization aligns with NIST 800-53 High Impact controls, aimed at handling sensitive, unclassified government data.
Analysts have responded positively to these developments. Scotiabank raised its price target for Qualys to $150, maintaining a Sector Perform rating, while DA Davidson increased its target to $135, keeping a Neutral rating. Jefferies also adjusted its price target to $150, describing the results as "better than feared." These adjustments reflect the company’s strong performance, including a notable EBITDA beat and an 8% year-over-year growth in current calculated billings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.